1,374 Shares in Cardinal Health, Inc. $CAH Purchased by Retireful LLC

Retireful LLC bought a new position in Cardinal Health, Inc. (NYSE:CAH) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 1,374 shares of the company’s stock, valued at approximately $231,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. MassMutual Private Wealth & Trust FSB raised its holdings in shares of Cardinal Health by 3.6% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company’s stock worth $297,000 after acquiring an additional 62 shares during the last quarter. Pinnacle Bancorp Inc. increased its stake in Cardinal Health by 11.2% in the 1st quarter. Pinnacle Bancorp Inc. now owns 767 shares of the company’s stock valued at $106,000 after buying an additional 77 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. increased its stake in Cardinal Health by 7.9% in the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,074 shares of the company’s stock valued at $181,000 after buying an additional 79 shares during the last quarter. Applied Finance Capital Management LLC increased its stake in Cardinal Health by 1.4% in the 1st quarter. Applied Finance Capital Management LLC now owns 6,049 shares of the company’s stock valued at $833,000 after buying an additional 85 shares during the last quarter. Finally, Perigon Wealth Management LLC increased its stake in Cardinal Health by 4.2% in the 1st quarter. Perigon Wealth Management LLC now owns 2,242 shares of the company’s stock valued at $309,000 after buying an additional 90 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Trading Down 0.1%

CAH opened at $154.50 on Thursday. The company has a 50 day moving average of $152.52 and a 200 day moving average of $148.91. The company has a market cap of $36.71 billion, a PE ratio of 23.95, a price-to-earnings-growth ratio of 1.31 and a beta of 0.73. Cardinal Health, Inc. has a 12 month low of $106.54 and a 12 month high of $168.44.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping the consensus estimate of $2.03 by $0.05. The company had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. Cardinal Health’s revenue for the quarter was up .5% on a year-over-year basis. During the same period last year, the firm earned $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Research analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a $0.5107 dividend. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 annualized dividend and a yield of 1.3%. Cardinal Health’s dividend payout ratio (DPR) is 31.63%.

Insider Buying and Selling

In related news, insider Michelle D. Greene sold 13,500 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $2,009,070.00. Following the completion of the transaction, the insider directly owned 14,976 shares of the company’s stock, valued at approximately $2,228,728.32. This trade represents a 47.41% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Ola M. Snow sold 28,151 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the completion of the transaction, the insider directly owned 15,431 shares of the company’s stock, valued at approximately $2,298,293.14. This trade represents a 64.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 271,676 shares of company stock worth $40,489,525 in the last 90 days. 0.12% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on CAH shares. Leerink Partners decreased their price objective on shares of Cardinal Health from $188.00 to $186.00 and set an “outperform” rating for the company in a research note on Tuesday, August 12th. UBS Group reiterated a “buy” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Robert W. Baird increased their price objective on shares of Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a research note on Wednesday, August 13th. Wall Street Zen lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. Finally, Citigroup reiterated a “neutral” rating and issued a $170.00 price objective (up previously from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Eleven investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average price target of $165.93.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.